The US Food and Drug Administration (FDA) has rejected the approval of the drug “Evonesimab” for the treatment of lung ...
Washington – The U.S. Food and Drug Administration (FDA) on Sunday rejected Summit Therapeutics’ application for approval of the lung cancer drug ifonisimab. This move represents a setback for medical efforts to expand treatment options for patients, …